CVS Health price target raised to $61 from $60 at Wells Fargo

Wells Fargo raised the firm’s price target on CVS Health to $61 from $60 and keeps an Equal Weight rating on the shares. Following Q2 results, the firm co-hosted a meeting with CVS management team. Unsurprisingly, nearly all focus was on struggles at Aetna, Wells says. While visibility remains low, earnings power could clearly be much higher in 2-3 years if company can execute well, the firm adds.